DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Hosaka T, Suzuki F, Kobayashi M. et al.
HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy.
Liver Int 2010;
30 (10) 1461-1470
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.